$1.52B
$2.1 Million
0.0% of portfolio
83,631
Q4 2024
Added 7.39%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 13.25%
$149M
$240,000
0.0% of portfolio
27,479
Q4 2024
Added 1.7%
$879M
$1.62 Million
0.0% of portfolio
227,700
Q4 2024
Added 0.87%
$12.1B
$5.33 Million
0.0% of portfolio
117,415
Q4 2024
Added 5.85%
$104B
$807,000
0.0% of portfolio
69,395
Q4 2024
Reduced 0.55%
$305M
$203,000
0.0% of portfolio
17,696
Q4 2024
Added 0.49%
Piraeus Financial Unsp Adr
-
$0
0.0% of portfolio
-
Q4 2024
Added 56.96%
$1.5B
$3.47 Million
0.0% of portfolio
478,798
Q4 2024
Reduced 1.33%
-
$0
0.0% of portfolio
-
Q3 2023
New
$1.49B
$1.16 Million
0.0% of portfolio
287,258
Q4 2024
Added 4.96%
$449M
$759,000
0.0% of portfolio
65,870
Q4 2024
Added 0.54%
$195M
$242,000
0.0% of portfolio
130,360
Q4 2024
Added 1.5%
$2.62B
$297,000
0.0% of portfolio
42,809
Q4 2024
Added 2.93%
$4.97B
$591,000
0.0% of portfolio
26,682
Q4 2024
Added 0.17%
$379M
$1.22 Million
0.0% of portfolio
92,580
Q4 2024
Reduced 2.24%
$1.07B
$2.71 Million
0.0% of portfolio
1,271,676
Q4 2024
Reduced 15.31%
$265M
$281,000
0.0% of portfolio
5,964
Q4 2024
Added 0.69%
$656M
$1.31 Million
0.0% of portfolio
73,529
Q4 2024
Added 1.39%
$2.31B
$4,000
0.0% of portfolio
4,694
Q4 2024
Reduced 3.87%
Polyus Pjsc Sponsored Adr
-
$0
0.0% of portfolio
-
Q2 2023
New
Ponce Financial Group Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.17%
$441M
$380,000
0.0% of portfolio
77,277
Q4 2024
Added 30.42%
$17.5B
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.81%
$641M
$760,000
0.0% of portfolio
80,861
Q4 2024
Added 3.51%
$12.3B
$1.84 Million
0.0% of portfolio
42,462
Q4 2024
Added 5.38%
$815M
$1.09 Million
0.0% of portfolio
113,431
Q4 2024
Added 8.55%
$254M
$490,000
0.0% of portfolio
37,591
Q4 2024
Added 0.84%
$365M
$346,000
0.0% of portfolio
36,764
Q4 2024
Added 0.04%
$181M
$685,000
0.0% of portfolio
137,451
Q4 2024
Added 9.28%
$902M
$2.5 Million
0.0% of portfolio
119,574
Q4 2024
Reduced 2.06%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1,053.87%
Praxis Precision Medicines Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.5%
$354M
$220,000
0.0% of portfolio
197,134
Q4 2024
Added 7.26%
-
$0
0.0% of portfolio
-
Q3 2024
New
$758M
$0
0.0% of portfolio
3
Q2 2024
Reduced 40.0%
$725M
$501,000
0.0% of portfolio
3,921
Q4 2024
Added 0.93%
$36.7M
$211,000
0.0% of portfolio
166,830
Q4 2024
Added 1,289.79%
$999M
$1.45 Million
0.0% of portfolio
56,879
Q4 2024
Reduced 0.14%
Prevail Therapeutics Inc Cvr
-
$0
0.0% of portfolio
-
Q1 2022
Reduced 1.14%
$236M
$210,000
0.0% of portfolio
71,956
Q4 2024
Added 2.73%
$382M
$174,000
0.0% of portfolio
795
Q4 2024
Reduced 9.97%
$275M
$826,000
0.0% of portfolio
70,869
Q4 2024
Added 94.29%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.25%
-
$0
0.0% of portfolio
-
Q4 2024
Added 9.03%
$800M
$2.56 Million
0.0% of portfolio
160,707
Q4 2024
Added 0.8%
$3.1B
$4.94 Million
0.0% of portfolio
61,296
Q4 2024
Added 5.58%
-
$0
0.0% of portfolio
-
Q4 2024
Added 7.87%
$0
$0
0.0% of portfolio
34,026
Q4 2024
Added 0.29%